BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma Z, Pi J, Zhang Y, Qin H, Zhang B, Li N, Li Z, Liu Z. Enhanced Anticancer Efficacy of Dual Drug-Loaded Self-Assembled Nanostructured Lipid Carriers Mediated by pH-Responsive Folic Acid and Human-Derived Cell Penetrating Peptide dNP2. Pharmaceutics 2021;13:600. [PMID: 33921919 DOI: 10.3390/pharmaceutics13050600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang B, Zhang Y, Dang W, Xing B, Yu C, Guo P, Pi J, Deng X, Qi D, Liu Z. The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01628-x] [Reference Citation Analysis]
2 Loo YS, Zahid NI, Madheswaran T, Mat Azmi ID. Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer. Journal of Drug Delivery Science and Technology 2022;71:103300. [DOI: 10.1016/j.jddst.2022.103300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mi X, Hu M, Dong M, Yang Z, Zhan X, Chang X, Lu J, Chen X. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy. Int J Nanomedicine 2021;16:8337-52. [PMID: 34992370 DOI: 10.2147/IJN.S340764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang H, Zang J, Zhao Z, Zhang Q, Chen S. The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation. Int J Nanomedicine 2021;16:7663-81. [PMID: 34815670 DOI: 10.2147/IJN.S328705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
5 Bertoni S, Passerini N, Albertini B. Liquid Lipids Act as Polymorphic Modifiers of Tristearin-Based Formulations Produced by Melting Technologies. Pharmaceutics 2021;13:1089. [PMID: 34371779 DOI: 10.3390/pharmaceutics13071089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]